Mefloquine and new related compounds target the F(0) complex of the F(0)F(1) H(+)-ATPase of Streptococcus pneumoniae.
about
Variations of Subunit of the Mycobacterium tuberculosis F1Fo ATP Synthase and a Novel Model for Mechanism of Action of the Tuberculosis Drug TMC207Mutations in pfmdr1 modulate the sensitivity of Plasmodium falciparum to the intrinsic antiplasmodial activity of verapamilViridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniaeThe role of host and microbial factors in the pathogenesis of pneumococcal bacteraemia arising from a single bacterial cell bottleneck.Molecular characterization of disease-associated streptococci of the mitis group that are optochin susceptibleGenetic characterization of optochin-susceptible viridans group streptococci.Characterization of in vitro-generated and clinical optochin-resistant strains of Streptococcus pneumoniae isolated from Argentina.Is repositioning of drugs a viable alternative in the treatment of tuberculosis?Targeting Phenotypically Tolerant Mycobacterium tuberculosis.High-efficiency generation of antibiotic-resistant strains of Streptococcus pneumoniae by PCR and transformation.The mystery of the fourth clone: comparative genomic analysis of four non-typeable Streptococcus pneumoniae strains with different susceptibilities to optochin.Phenotypic and molecular characterization of optochin-resistant Streptococcus pneumoniae isolates from Brazil, with description of five novel mutations in the ATPC gene.Characterization of recombinant fluoroquinolone-resistant pneumococcus-like isolates.
P2860
Q27674675-EC5E331B-1213-4FB6-A3B4-53FAB785C2E7Q33807087-B0A53799-F7EE-4690-9177-48B51A420087Q35102420-74DF83D7-A5EA-4CA0-AB1F-91FB52C8D68CQ35126697-A00D3F58-CA35-4449-B501-C51CB6123890Q35220890-3B8C880B-9DA3-4A77-BB1B-673A2B6DD894Q36047248-3580F17F-E801-4B97-A3DE-C739C6FA088FQ36747410-FFED1964-38EC-4EE0-A656-824F8945D146Q38053000-7F0F48C5-4BB9-4653-8ABF-7DAA65B1870CQ39149038-0D211F16-B60B-4DC7-AB7B-1D393D91AD62Q39743528-58692ED4-2E6B-4B91-85DD-31EBBA85323DQ40911614-094196D5-E2A3-4480-BFC8-B4AB3537F655Q41821802-11B37D29-B49C-4AB3-826A-E88BB69A5D7BQ42088108-E9D2CC11-2860-4FE2-ACB0-7C0AC4D9258A
P2860
Mefloquine and new related compounds target the F(0) complex of the F(0)F(1) H(+)-ATPase of Streptococcus pneumoniae.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mefloquine and new related compounds target the F
@nl
Mefloquine and new related com ...... e of Streptococcus pneumoniae.
@ast
Mefloquine and new related com ...... e of Streptococcus pneumoniae.
@en
type
label
Mefloquine and new related compounds target the F
@nl
Mefloquine and new related com ...... e of Streptococcus pneumoniae.
@ast
Mefloquine and new related com ...... e of Streptococcus pneumoniae.
@en
prefLabel
Mefloquine and new related compounds target the F
@nl
Mefloquine and new related com ...... e of Streptococcus pneumoniae.
@ast
Mefloquine and new related com ...... e of Streptococcus pneumoniae.
@en
P2093
P2860
P1476
Mefloquine and new related com ...... e of Streptococcus pneumoniae.
@en
P2093
Adela G de la Campa
Antonio Javier Martín-Galiano
Begoña Gorgojo
Calvin M Kunin
P2860
P304
P356
10.1128/AAC.46.6.1680-1687.2002
P407
P577
2002-06-01T00:00:00Z